← Back to Clinical Trials
Recruiting NCT05866991

NCT05866991 Cohort of Patients Suffering From Major Depressive Episode With Evaluation of Sleep, Circadian Rhythms and Psychiatric Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05866991
Status Recruiting
Phase
Sponsor Assistance Publique - Hôpitaux de Paris
Condition Major Depressive Episode
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2023-02-01
Primary Completion 2033-02-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2023-02-01 with a primary completion date of 2033-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Despite international efforts to identify biomarkers of depression, none has been transferred to clinical practice, neither for diagnosis, evolution, nor therapeutic response. This led us to build a French national cohort (through the clinical and research network named SoPsy within the French biological psychiatry society (AFPBN) and sleep society (SFRMS)), to better identify markers of sleep and biological rhythms and validate more homogeneous subgroups of patients, but also to specify the manifestations and pathogeneses of depressive disorders.

Eligibility Criteria

Inclusion Criteria: * Individuals with depressive episode characterized according to the DSM-5 criteria regardless of the associated characteristics and comorbidities. * Adult and child * Affiliated to a social security Exclusion Criteria: * don't understand or read french * Medical condition incompatible with administration of questionnaire * impossibility to give informed decision (subject in an emergency condition, etc.)

Contact & Investigator

Central Contact

Pierre Alexis GEOFFROY, PU-PH

✉ Pierrealexis.geoffroy@aphp.fr

📞 01 40 25 82 62

Frequently Asked Questions

Who can join the NCT05866991 clinical trial?

This trial is open to participants of all sexes, studying Major Depressive Episode. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05866991 currently recruiting?

Yes, NCT05866991 is actively recruiting participants. Contact the research team at Pierrealexis.geoffroy@aphp.fr for enrollment information.

Where is the NCT05866991 trial being conducted?

This trial is being conducted at Paris, France.

Who is sponsoring the NCT05866991 clinical trial?

NCT05866991 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology